Ergoteles LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 104 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$169,175
-37.2%
50,500
-9.9%
0.01%
-30.0%
Q4 2022$269,509
-91.3%
56,031
+11.3%
0.01%
-89.7%
Q1 2021$3,110,00050,3620.10%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$3,780,00035.90%
BML Capital Management, LLC 4,800,000$14,400,00013.22%
Stonepine Capital Management, LLC 1,720,000$5,160,0001.71%
TANG CAPITAL MANAGEMENT LLC 3,600,000$10,800,0001.52%
CM Management, LLC 275,000$825,0000.88%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,456,9140.83%
EcoR1 Capital, LLC 6,995,861$20,987,5830.71%
SECTORAL ASSET MANAGEMENT INC 600,461$1,801,3830.35%
Newtyn Management, LLC 400,000$1,200,0000.30%
Diametric Capital, LP 200,000$600,0000.25%
View complete list of ATEA PHARMACEUTICALS INC shareholders